Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

It is my pleasure to announce that Dr. Sophie Lerouge and Dr. Lauren Flynn have been elected by board of directors as CBS representatives for the IUS-BSE for the period of 2020-2024...

We are very pleased to inform you that Dr. Diego Mantovani has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Service Award, acknowledging his outstanding contributions to our Society...

On behalf of CBS Award committee, we wish Dr. Felipe Eltit a hearty congratulation on receiving the CBS Visiting Scholar Award of the year...

Canadian universities provide world-recognized training in research and leadership for their graduate students...

Glioblastoma is one of the most aggressive forms of cancer. It is the most common of all malignant central nervous system tumours and the deadliest primary brain cancer...

Optic neuropathy is a common cause of vision loss resulting from death of retinal ganglion cells due to insufficient blood flow, inflammation, infection or trauma...

Genetically tailored human mesenchymal stem cells MSC are studied extensively to develop cell-based therapies for bone defects...

Nanogels have received huge attention in the past decade due to their non-toxic properties and the ability to encapsulate small molecules for drug delivery that enhance the therapeutic potency of the drugs 1 ...

Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...